By altering the Akt signaling pathway, GLPs improved the radiosensitization of hepatocellular carcinoma cells, indicating a possible therapeutic use for GLPs as radiosensitizers in the treatment of HCC (88). This evidence concerns the gene AKT1 and hepatocellular carcinoma.